| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Allergy and Clinical Immunology, University of Rome "La Sapienza," Rome, Italy;
Department of Anatomy and Histology, University of Florence, Florence, Italy; and
Department of Cell and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Neurologic abnormalities are common in HIV-1-infected patients and often represent the dominant clinical manifestation of pediatric AIDS. The neurological dysfunction has been directly related to CNS invasion by HIV-1 that is principally, if not exclusively, supported by blood-derived monocytes/macrophages and lymphocytes. By using primary long term cultures of human fetal sensory neurons as well as sympathetic precursors-like neuronal cells, we determined that blood-derived mononuclear cells from HIV-1-infected individuals spontaneously release soluble mediators that can potently inhibit the growth and survival of developing neurons as well as the viability of postmitotic neuronal cells by inducing apoptotic cell death. Analysis of the cytokines produced by lymphomonocytic cells, HIV-1 infected or activated, indicated that oncostatin M (oncM) is a major mediator of these effects. Since low TGF-ß1 concentrations were capable of enhancing oncM-mediated neuronal alterations, our data indicate that by acting in concert with other cytokines, oncM may induce neuronal demise in both the developing and the mature brain. Thus, this cytokine may contribute to the setting of the neuronal cell damage observed in HIV-1-infected individuals.
This article has been cited by other articles:
|
|
 |
|
  S. P. Kastl, W. S. Speidl, C. Kaun, K. M. Katsaros, G. Rega, T. Afonyushkin, V. N. Bochkov, P. Valent, A. Assadian, G. W. Hagmueller, et al. In Human Macrophages the Complement Component C5a Induces the Expression of Oncostatin M via AP-1 Activation Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 498 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Weiss, A. L. Samson, B. Niego, P. B. Daniel, and R. L. Medcalf Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo FASEB J, November 1, 2006; 20(13): 2369 - 2371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Igaz, R. Salvi, J.-P. Rey, M. Glauser, F. P. Pralong, and R. C. Gaillard Effects of Cytokines on Gonadotropin-Releasing Hormone (GnRH) Gene Expression in Primary Hypothalamic Neurons and in GnRH Neurons Immortalized Conditionally Endocrinology, February 1, 2006; 147(2): 1037 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sui, R. Potula, N. Dhillon, D. Pinson, S. Li, A. Nath, C. Anderson, J. Turchan, D. Kolson, O. Narayan, et al. Neuronal Apoptosis Is Mediated by CXCL10 Overexpression in Simian Human Immunodeficiency Virus Encephalitis Am. J. Pathol., May 1, 2004; 164(5): 1557 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Ensoli, V Fiorelli, A Lugaresi, D Farina, M DeCristofaro, B Collacchi, D S. Muratori, E Scala, M Di Gioacchino, R Paganelli, et al. Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors {alpha} and {beta}, and interferon {gamma} Multiple Sclerosis, August 1, 2002; 8(4): 284 - 288. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Repovic and E. N. Benveniste Prostaglandin E2 Is a Novel Inducer of Oncostatin-M Expression in Macrophages and Microglia J. Neurosci., July 1, 2002; 22(13): 5334 - 5343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Patrick Synaptic Clefts Are Made to Be Crossed: Neurotransmitter Signaling in the Central Nervous System Toxicol Pathol, January 1, 2000; 28(1): 31 - 36. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
